retatrutide parkinson's disease trial nct acetate (LY3437943 acetate) | GCGR/GIPR/GLP-1R Agonist Retatrutide approval: FDA status, clinical
Pay in 4 interest-free payments of $5.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




























